Skip to content
Search

Latest Stories

GPhC announces pre-registration exam date

The General Pharmaceutical Council has announced that it will hold two separate sittings of the online pre-registration assessment in March next year.

The exams will take place at Covid-secure Pearson VUE test centres. There will be two sittings – each with different papers – and candidates will sit the two papers which make up the assessment at one of their local Pearson VUE centres on one day, either Wednesday March 17, or Thursday March 18 2021.


The application form will open in January. Candidates need to apply to sit the assessment through their myGPhC account and those who need any ‘reasonable adjustment’ can request for it using the same form.

The GPhC emphasises that although the way in which candidates will sit the assessment will be different this time, the types of questions used and the standard required to pass it will remain the same as in previous years.

Meanwhile, the Royal Pharmaceutical Society has welcomed the announcement, and is calling for further details to be clarified as quickly as possible.

"Trainees will be concerned about reasonable adjustments especially when there may be a last minute change such as a requirement to self-isolate at short notice," said RPS director for education Gail Fleming said.

"We're now urging GPhC to act quickly to publish the further details they have committed to providing. These are urgently needed to alleviate the ongoing concerns of those due to sit the assessment.

“We know how stressful it's been for trainees waiting for details of the exam, whilst working hard to support patients and the public during these difficult times.”

More For You

Imported dengue reach record high, warns UKSHA

Most dengue cases were linked to travel to Southern and South-Eastern Asia.

Getty Images

Imported dengue cases hit record high – Consult your pharmacist before you travel

The UK Health Security Agency (UKSHA) has warned that imported dengue cases in England, Wales, and Northern Ireland (EWNI) have reached their highest level since dengue surveillance began in 2009.

New data from the agency reveals that 904 dengue cases were reported among returning travellers in these countries in 2024, a sharp increase from 631 in 2023.

Keep ReadingShow less
Henry Gregg named as new NPA chief executive

Henry Gregg (left) with Sir Chris Whitty

Pic credit: Henry Gregg/X

Henry Gregg named as new NPA chief executive

The National Pharmacy Association (NPA) has announced Henry Gregg will be the organisation’s new chief executive from May.

Gregg, who is currently director of external affairs at Asthma + Lung UK, replaces Paul Rees who departed in January.

Keep ReadingShow less
Kelso Pharma continues expansion with £140M funding boost

Kelso Pharma will use the funds to support further acquisitions and expand in the UK and Europe.

Getty Images

Kelso Pharma secures over £140m of acquisition funding

Kelso Pharma has secured more than £140 million of acquisition funding to support its expansion in the UK and across Europe.

The specialty pharmaceuticals business today (27) confirmed that a proportion of the funding was used for its acquisition of ALTURiX last month, a deal that doubled the size of the company’s UK business.

Keep ReadingShow less
Community pharmacist accessing GP Connect Access Record on Cegedim Rx platform

GP Connect Access Record will make a patient’s relevant medical information available to pharmacy.

Getty Images

Cegedim Rx activates GP Connect Access Record

Community pharmacy IT supplier Cegedim Rx has made GP Connect Access Record functionality available across its clinical services platform, providing registered pharmacy professionals with enhanced access to patient medical information.

The new feature, now live on Cegedim Rx’s Pharmacy Services platform, allows community pharmacies to retrieve relevant medical data when delivering NHS clinical services.

Keep ReadingShow less
Prepayment certificates helped patients avoid £837M in prescription fees, NHSBSA analysis reveals

Patients who purchase two prescriptions per month could save more than £110 annually with a 12-month PPC.

Getty Images

Prepayment certificates helped patients avoid £837M in prescription fees, NHSBSA analysis reveals

The NHS Business Services Authority (NHSBSA) has published a new experimental analysis, estimating patient savings achieved from prescription prepayment certificates (PPCs), including Hormone Replacement Therapy (HRT) PPCs.

The report revealed that the number of Prescription Prepayment Certificates (PPCs) purchased has risen consistently over the past five years, with 3.3 million patients receiving NHS prescriptions under a PPC exemption in 2023/2024.

Keep ReadingShow less